CENTAC Releases BSMS, BHMS, BUMS Seat Matrix, Draft Merit List, Counselling on October 8

Puducherry- The Centralised Admission Committee (CENTAC) has recently published the schedule and Draft Merit list for BSMS, BHMS and BUMS courses on its official website. The draft Merit list is prepared based on the National Eligibility and Entrance Test-Undergraduate (NEET UG) 2024 score.

In this regard, CENTAC has published a notice informing that the objections if any, may be submitted through Grievances in the login dashboard or email on or before 07 October 2024, 11.00 am. No, objections will be allowed after the last date. After disposing of the objections, if any, the Final Merit List will be published on 07 October 2024.

Meanwhile, physical Counselling for BSMS, BHMS and BUMS courses is scheduled on Tuesday, 08 October 2024 at 11.00 a.m. at CENTAC Office, Puducherry.

Along with this, CENTAC has also released the seats available for the BSMS, BHMS and BUMS courses. As per the seats matrix, a total of 5 seats are available in the said courses for the academic year 2024. Of these, 2 seats are vacant in BSMS, 2 seats are vacant in BHMS and 1 seat is vacant in BUMS.

Also Read: CENTAC Extends Deadlines for NEET 2024 Round 2 Registration, Round 1 Seat Withdrawal, Course Preference Submission

SEATS AVAILABILITY

S.NO

COURSE

COLLEGE

NO.OF SEATS

1

BSMS

Government Siddha Medical College, Palayamkottai, TN.

2

2

BHMS

Government Homoeo Medical College, Thirumangalam, Madurai, TN.

1

3

BHMS

Government Homeo Medical College, Bangalore, Karnataka.

1

4

BUMS

Government Unani College, Chennai, TN.

1

TOTAL

5

IMPORTANT POINTS

1 Candidates should report with all original certificates including Marksheets, and Renewed Residence certificates for counselling.

2 Candidates once allotted BSMS, BHMS and BUMS course seats will not be considered for further rounds of counselling for and course in CENTAC.

CENTAC is a common admission portal for all the colleges of Puducherry and is established by the Government of Puducherry. Under this, the candidates who have passed the qualifying examination and appeared in such a qualifying examination are eligible for admission. There are various courses under its umbrella. Centralised Admission Committee (CENTAC), Government of Puducherry, conduct admissions for first-year MBBS, BAMS, BDS, BVSc & AH, BPT, BSc (Nursing), BSc (MLT), B Pharma, and postgraduate programmes, etc.

To view the notice, click the link below

https://medicaldialogues.in/pdf_upload/centac-releases-bsms-bhms-bums-seat-matrix-draft-merit-list-objections-invited-before-october-7-255533.pdf


from Medical News, Health News Latest, Medical News Today - Medical Dialogues | https://ift.tt/iUVsnx1

Comments

Post a Comment

Popular posts from this blog

'Details sought include Third-party info, hence exempted under RTI Act': NMC on RTI query on Faculty Gap in Medical Colleges

Image
New Delhi:  Stating that the details sought under the RTI includes third-party information, the National Medical Commission (NMC) has refused to disclose the names of the medical colleges that fell short on faculty counts and other teaching infrastructure. Recently activist Dr. KV Babu filed an application under the Right to Information Act seeking the details of the notices issued by the NMC Undergraduate Medical Education Board (UGMEB) to the medical colleges for deficiencies in Clinical Material and staff during the period from 01/01/2023 to 30/04/2024. He also sought to know the details of the fine imposed or the action taken by the NMC UG Board from 01/01/2023 to 30/04/2024. In response, the Apex medical regulatory body in India has said that the concerned information includes third party information. "Since the information sought by you, includes third party information, hence the same is exempted for as per Section 8(1) (j) of the Right to Information Act, 2005," th...
Read more

Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA

Image
A recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate to severe plaque psoriasis. Psoriasis is a chronic inflammatory skin condition characterized by red, scaly patches, affects millions throughout the globe. While several treatments exist, the demand for new, effective, and well-tolerated oral therapies remains high. Zasocitinib, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, emerges as a promising candidate to meet this need. This trial was conducted between August 2021 and September 2022 across 55 centers in the US and Canada and found that Zasocitinib not only significantly improved skin clearance in patients but also expressed a favorable safety and tolerability profile. The study enrolled a total of 287 participants aged between 18 and 70 years, each with a Psoriasis Area and Severity Index (PASI) score of 12 or greater, a Physician’s Global Assessment score of 3...
Read more

New wearable laser device may monitor brain blood flow to gauge stroke risk, reports research

Image
Researchers have developed a laser-based device that can be placed on the head to non-invasively monitor changes in brain blood flow and volume. The new device could one day help save lives by offering a direct and simple way to assess stroke risk based on physiological markers rather than indirect markers like lifestyle factors. Strokes occur when blood flow to the brain is blocked or reduced, causing debilitating brain cell damage. With about 15 million people worldwide affected by strokes each year, it is the second leading cause of death and a leading cause of long-term disability. “The lack of a cost-effective and scalable stroke risk assessment system complicates long-term stroke prevention because a physician can’t tell whether a patient’s risk is stable or worsening,” said research team member Simon Mahler, a postdoctoral scholar in Changhuei Yang’s laboratory at the California Institute of Technology. “This new method could help catch early signs of increased stroke risk, w...
Read more